The role of inflammation in the development of epilepsy.

Rana A, Musto AE. · 2018

Read The role of inflammation in the development of epilepsy. by Rana A, Musto AE. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5952578.txt.

Introduction

Rana and Musto review the role of inflammation in the development of epilepsy. Their review appeared in the Journal of Neuroinflammation. Epilepsy often follows earlier injury to the nervous system. Poor control of inflammation in injured tissue may be a key step. How that imbalance drives epilepsy is still unclear. The authors trace inflammatory pathways that may link the two.

They review inflammatory molecules in brain and body-wide disorders. Rheumatoid arthritis, Crohn's disease, and type 1 diabetes are covered. Such molecules could feed the process that ends in seizures. Blood-brain barrier breakdown also features in the picture. The authors argue this knowledge could yield risk markers. It may also point to new preventive treatments.

Catalog record

CREATORRana A, Musto AE.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5952578

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The role of inflammation in the development of epilepsy By Amna Rana, Alberto E Musto Published in: Journal of Neuroinflammation DOI: 10.1186/s12974-018-1192-7 ABSTRACT Abstract Epilepsy, a neurological disease characterized by recurrent seizures, is often associated with a history of previous lesions in the nervous system. Impaired regulation of the activation and resolution of inflammatory cells and molecules in the injured neuronal tissue is a critical factor to the development of epilepsy. However, it is still unclear as to how that unbalanced regulation of inflammation contributes to epilepsy. Therefore, one of the goals in epilepsy research is to identify and elucidate the interconnected inflammatory pathways in systemic and neurological disorders that may further develop epilepsy progression. In this paper, inflammatory molecules, in neurological and systemic disorders (rheumatoid arthritis, Crohn’s, Type I Diabetes, etc.) that could contribute to epilepsy development, are reviewed. Understanding the neurobiology of inflammation in epileptogenesis will contribute to the development of new biomarkers for better screening of patients at risk for epilepsy and new therapeutic targets for both prophylaxis and treatment of epilepsy. Keywords: Epileptogenesis, Inflammation, Neurological disorders, Systemic inflammatory disorders, Blood–brain barrier (BBB) breakdown BACKGROUND Epilepsy is a multifaceted neurological disease, characterized by recurrent spontaneous seizures. Despite the efficacy of current anti-epileptic drugs, almost 30% of patients with epilepsy are refractory to medical treatment, have progressive cognitive impairment, and may require neurosurgical resection of the epileptic focus to ameliorate seizure recurrence [1]. It has been widely ascertained that the development of epilepsy-epileptogenesis can be owed to a diverse array of factors, including genetic predisposition, developmental dysfunction, and neurological insult, which contribute to morphological synaptic changes and hyper-excitable neuronal transmission [2]. For instance, a history of familial epilepsy, neurodevelopmental abnormality, and generation of complex febrile seizures are associated with the highest risk of epilepsy development in infants [2, 3]. Moreover, neurological insult, such as traumatic brain injury, hypoxia, or febrile seizures, is associated with neuronal death, dysfunctional synaptic modification, and the generation of a hyper-excitable network, which could predispose to spontaneous recurrent seizures [1]. Brain injury induces a highly regulated cascade of biological events, characterized by the release of cytokines, chemokines, lipid mediators, and protectins in the neuronal microenvironment [4, 5]. Physiologically, inflammatory mediators activate their corresponding receptors on different brain cells to stimulate various pathways of molecular signaling and to initiate brain repair [6]. Deregulation of mediator and receptor expression could sustain neuronal damage, which would clinically manifest depending on the region of the brain affected [7]. Although the cellular and molecular mechanisms of epileptogenesis are not clear, it is postulated that focal or systemic unregulated inflammatory processes lead to aberrant neural connectivity and the hyper-excitable neuronal network, which mediate the onset of epilepsy [4, 8]. This review discusses critical inflammatory events, from neuronal tissue (central inflammation), BBB integrity and systemic inflammatory disorders (peripheral inflammation), that could contribute to epilepsy and may hold potential as molecular biomarkers and targets for therapeutic approaches for epilepsy (Fig. 1). [Figure: Sources and targets of unregulated and overlapped components of inflammation in epileptogenesis. Brain injury induces central inflammation and aberrant neuronal connectivity within the hippocampus. Systemic inflammatory disorders generate peripheral inflammation which can further contribute to the buildup of inflammatory mediators. Peripheral and central inflammation allow for the breakdown of the blood–brain barrier due to the upregulation of inflammatory mediators. BBB breakdown permits leukocyte infiltration which generates neuronal hyper-excitability and further upregulates inflammatory mediators. Unregulated peripheral and central inflammation and breakdown of the blood–brain barrier lead to morphological synaptic changes within the hippocampus and ultimately, the development of epilepsy] INFLAMMATION IN THE CENTRAL NERVOUS SYSTEM Epileptogenesis is associated, along with subtle neuronal damage, gliosis, and microgliosis, with an increased, strong, and persistent inflammatory state in the microenvironment of neural tissue [9]. Inflammatory processes may originate in the central nervous system or be acquired from systemic circulation through a breakdown in the blood–brain barrier (BBB) [10]. A wider breadth of research on neuro-inflammation and epilepsy has focused on hippocampal foci as opposed to extra-hippocampal foci of epilepsy due to the well-documented pathology, physiology, and clinical manifestations of hippocampal atrophy and sclerosis. However, evidence has also associated neuro-inflammation with extra-hippocampal neuronal cell death and gliosis [11]. Various clinical trials with TSPO (translocator protein expressed by activated microglia) positron emission tomography (PET) have linked seizures, induced in temporal lobe epilepsy, frontal lobe epilepsy, and focal cortical dysplasia, with ensuing acute neuro-inflammation. The acute bout of neuro-inflammation is thought to contribute to and worsen a pre-existing state of chronic neuro-inflammation [12]. For instance, patients with multiple sclerosis (MS) have increased risk for epilepsy development when MS is associated with the development of pure intracortical lesions, which cause extensive cortical inflammation [13]. A deeper understanding of the chemical mediators and receptors relevant to neuro-inflammation may elucidate their neurobiological mechanistic contribution to epileptogenesis. Cytokines Cytokines, proteins that modulate inflammatory processes, are primarily produced by glial cells and neurons during brain inflammation [9]. Pro-inflammatory cytokines, interleukin-1β (IL-Iβ), IL-2, and IL-6, typically concentrated in low quantities within the brain, increase after seizures [14]. In a clinical study, febrile seizures increased levels of cytokines IL-1β, IL-6, and tumor necrosis factor- α (TNF-α) in cerebrospinal fluid [15]. In addition, mRNA expression of cytokines IL-1β, IL-6, and TNF-α, along with transforming growth factor- beta 1 (TGF-β1) and vascular endothelial growth factor (VEGF), is upregulated in the hippocampus following seizures [14, 16, 17]. Such key cytokines and cytokine receptors implicate various mechanistic inflammatory pathways which cause detrimental synaptic changes and neuronal hyper-excitability. Interleukin-1β Pro-inflammatory cytokine IL-Iβ, expressed in activated microglia and astrocytes, enhances the release of glutamate from astrocytes and decreases glutamate re-uptake, thereby increasing glutamate availability in neuronal synapses and promoting neuronal hyper-excitability [9]. It has been suggested that IL-1β induces seizures through the upregulation of NMDA receptors on post-synaptic cells via an activation of the GluN2B subunit of the NMDA receptor [18]. Postnikova et al., using models of epilepsy, found that the production of the GluN2B mRNA increases 24 h after seizures and that changes in NMDA receptors may lead to impaired synaptic plasticity [19]. It has also been reported that induced seizures decreased long-term potentiation (LTP), a physiological marker of synaptic strength via normal plasticity, while IL-1β antagonist anakinra increased LTP. These findings suggest that unregulated levels of IL-1β impair physiologic synaptic plasticity and may cause potential neuronal dysfunction [16]. Another study by Roseti et al. shows that the pathophysiological concentrations of IL-1β in TLE decrease GABA-mediated neurotransmission by up to 30% and lead to seizure generation due to neuronal hyper-excitability [20]. Cytokine IL-1β has also been found to be significantly increased within the cerebrospinal fluid (CSF) in the epileptic pediatric population as opposed to the control group, suggesting the cytokine’s important role in epilepsy initiation and progression [21]. Tumor necrosis factor-α Pro-inflammatory cytokine TNF-α is released from activated microglia and astrocytes. Glial cells sense extracellular glutamate levels and, upon detection of low levels of glutamate, release TNF-α to upregulate synapses and maintain a certain level of neuronal excitatory input [22]. It has been reported that TNF-α regulates N-cadherin, an adhesion molecule involved in the formation and organization of excitatory and inhibitory synapses [23]. Furthermore, TNF-α has been found to increase microglial glutamate release through the upregulation of glutaminase and

Read the complete text